Asthma L1-L4 Study Set

0.0(0)
Studied by 0 people
call kaiCall Kai
learnLearn
examPractice Test
spaced repetitionSpaced Repetition
heart puzzleMatch
flashcardsFlashcards
GameKnowt Play
Card Sorting

1/52

encourage image

There's no tags or description

Looks like no tags are added yet.

53 Terms

1
New cards

Asthma definition

Heterogeneous, chronic inflammatory airway disease with excessive variation in expiratory lung function and respiratory symptoms.

2
New cards

Asthma symptoms

Cough, wheeze, dyspnoea, and chest tightness.

3
New cards

Circadian pattern of lung function in asthma

Worst on waking (and at 2-6 am); best around 12-2 pm.

4
New cards

Alarmins released by airway epithelium

IL-25, IL-33, and TSLP.

5
New cards

Role of IL-4 in asthma

Drives B-cell class switch and memory IgE production.

6
New cards

Role of IL-5 in asthma

Drives eosinophil maturation in bone marrow and recruitment to the lungs.

7
New cards

Role of IL-13 in asthma

Drives mucus production from goblet cells and airway hyperresponsiveness.

8
New cards

Target of Dupilumab

IL-4 receptor alpha (blocks IL-4 and IL-13 signalling).

9
New cards

Target of Mepolizumab

IL-5.

10
New cards

Target of Benralizumab

IL-5 receptor.

11
New cards

Target of Tezepelumab

TSLP (thymic stromal lymphopoietin).

12
New cards

FeNO (fraction of exhaled nitric oxide)

An indicator of the level of Th2 (eosinophilic) airway inflammation.

13
New cards

FeNO threshold for Th2-high asthma

Greater than 27 ppb.

14
New cards

Airway remodelling changes

Subepithelial fibrosis, smooth muscle hyperplasia/hypertrophy, goblet cell hyperplasia, and increased blood vessels.

15
New cards

Reversible airflow limitation (spirometry)

FEV1 increases by ≥200 mL AND ≥12% after bronchodilator.

16
New cards

Four criteria for assessing asthma control

Daytime symptoms, activity limitation, night/waking symptoms, and reliever use.

17
New cards

Good asthma control thresholds

Daytime symptoms ≤2 days/week, no activity limitations/night symptoms, and reliever ≤2 days/week.

18
New cards

Step up vs. Step down timing

Step up if poor control; step down if stable and controlled for 2-3 months.

19
New cards

Adult Level 1 Recommended Track

Budesonide-formoterol (low dose) as needed (AIR).

20
New cards

AIR vs. MART

AIR is PRN only; MART is regular maintenance plus PRN using the same inhaler.

21
New cards

Beta-agonists used as MART

Only formoterol-containing combinations (budesonide-formoterol or beclometasone-formoterol).

22
New cards

Formoterol duration of action

Approximately 12 hours (fast-acting like salbutamol, but long-lasting).

23
New cards

Budesonide-formoterol DPI 200/6 AIR limits

Max 6 puffs at once, 8 per day, 12 in one day temporarily.

24
New cards

Budesonide-formoterol pMDI 100/3 AIR limits

Max 12 puffs at once, 16 per day, 24 in one day temporarily.

25
New cards

Fostair (beclometasone-formoterol) MART limit

Maximum of 8 inhalations total per day.

26
New cards

Children 6-11 Level 2 treatment

Low-dose ICS maintenance + salbutamol PRN.

27
New cards

Why AIR is not recommended for children

AIR trials were only conducted in adults and adolescents.

28
New cards

Only ICS recommended for ages 1-5

Fluticasone propionate.

29
New cards

Why LABAs are never used alone in asthma

Using LABAs without an ICS increases the risk of asthma-related death.

30
New cards

M3 receptor role in airways

Causes airway smooth muscle contraction via Gq and increased calcium.

31
New cards

Beta2 receptor role in airways

Causes airway smooth muscle relaxation via Gs, cAMP, and PKA.

32
New cards

SABA overuse thresholds and risks

≥3 canisters/year = exacerbation risk; ≥12 canisters/year = death risk.

33
New cards

Tiotropium Respimat PBS criteria

Severe asthma uncontrolled on ICS-LABA with ≥1 severe exacerbation in past year.

34
New cards

Triple therapy (ICS/LABA/LAMA) criteria

Age 18+, ≥1 severe exacerbation requiring OCS despite optimised ICS-LABA.

35
New cards

ICS mechanism of trans-activation

GR complex binds GRE to up-regulate anti-inflammatory genes.

36
New cards

ICS mechanism of trans-repression

GR complex recruits HDAC2 to inhibit NF-κB, switching off inflammatory genes.

37
New cards

Why smokers have reduced ICS response

Smoking lowers HDAC2 levels, leading to steroid resistance.

38
New cards

Fluticasone furoate (FF) vs. propionate (FP) potency

FF is approximately 5 times more potent than FP.

39
New cards

ICS linear growth effect in children

Average final height difference of ~1.2 cm, mostly in year 1.

40
New cards

OCS dose for exacerbations

0.5-1 mg/kg (max 50 mg) for 3-5 days; no taper needed.

41
New cards

OCS stewardship toxic threshold

Cumulative lifetime dose of 1000 mg prednisolone-equivalent (~4 courses).

42
New cards

Montelukast neuropsychiatric warning

Can cause sleep disturbances, mood disorders, and suicidal ideation.

43
New cards

Severe asthma definition

Uncontrolled despite regular high-dose ICS-LABA, or requires it to prevent loss of control.

44
New cards

Difficult-to-treat vs. Severe refractory asthma

Difficult-to-treat has fixable issues (adherence, technique); refractory does not.

45
New cards

Vocal cord dysfunction (VCD) presentation

Voice change, throat clearing, and a throat-centred wheeze; unresponsive to ICS.

46
New cards

Aspirin-Exacerbated Respiratory Disease (AERD) triad

Asthma, nasal polyps (chronic rhinosinusitis), and aspirin/NSAID hypersensitivity.

47
New cards

AERD pathophysiology

COX inhibition drops protective PGE2, shunting arachidonic acid to produce bronchoconstricting leukotrienes.

48
New cards

Exercise-Induced Bronchoconstriction (EIB) diagnosis

Fall in FEV1 of ≥10% after exercise or osmotic challenge.

49
New cards

EIB osmolar theory

High ventilation evaporates airway water, cell shrinkage triggers leukotriene and histamine release.

50
New cards

EIB thermal theory

Cold air causes vasoconstriction; rewarming causes rebound hyperaemia and airway narrowing.

51
New cards

EIB prevention strategy

Warm up 10-15 min, breathe through nose, and use reliever 15 min before.

52
New cards

Inhaled salbutamol sport limit without TUE

1600 mcg per 24 hours, and maximum 600 mcg in any 8 hours.

53
New cards

Oral/IV glucocorticoids in competitive sport

Prohibited in-competition only; requires a TUE if used within 5-7 days.